Skip to main
TNMG
TNMG logo

TNL Mediagene (TNMG) Stock Forecast & Price Target

TNL Mediagene (TNMG) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

TNL Mediagene has demonstrated a robust financial performance, achieving a 35% year-over-year revenue increase in FY24, driven by significant momentum across its key segments. The company's digital advertising and marketing services are positioned to capture a larger share of advertising budgets, thanks to their optimized targeting and improved return on investment (ROI). Additionally, TNL Mediagene's active merger and acquisition pipeline is expected to support sustained annual revenue growth of 25-30% over the next three to four years, highlighting strong potential for continued expansion.

Bears say

TNL Mediagene faces significant risks related to its market entry strategies and merger and acquisition (M&A) integration, which could impair growth and erode shareholder value if not executed effectively. The company's ability to remain competitive hinges on its investment in artificial intelligence capabilities; failure to adapt could lead to obsolescence compared to more technologically advanced rivals. Additionally, as a recently listed Special Purpose Acquisition Company (SPAC), TNL Mediagene lacks a robust public track record, creating challenges in establishing investor confidence and consistent operational performance in the near term.

TNL Mediagene (TNMG) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of TNL Mediagene and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About TNL Mediagene (TNMG) Forecast

Analysts have given TNL Mediagene (TNMG) a Buy based on their latest research and market trends.

According to 1 analysts, TNL Mediagene (TNMG) has a Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

TNL Mediagene (TNMG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.